Antifibrinolytics do not add to the benefits of platelet transfusion

Affiliations

Comment

Charles A Schiffer. Lancet Haematol. 2025 Jan.

. 2025 Jan;12(1):e2-e3.

doi: 10.1016/S2352-3026(24)00343-0. Epub 2024 Dec 3.

¹ Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, USA. Electronic address: schiffer@karmanos.org.

No abstract available

Comment on

Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial.
TREATT Trial Investigators. TREATT Trial Investigators. Lancet Haematol. 2025 Jan;12(1):e14-e22. doi: 10.1016/S2352-3026(24)00317-X. Epub 2024 Dec 3. Lancet Haematol. 2025. PMID: 39642900 Clinical Trial.